Menu
Home Explore People Places Arts History Plants & Animals Science Life & Culture Technology
On this page
ATC code L02
Therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System: Endocrine therapy

ATC code L02 Endocrine therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup L02 is part of the anatomical group L Antineoplastic and immunomodulating agents.

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL02. National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

We don't have any images related to ATC code L02 yet.
We don't have any YouTube videos related to ATC code L02 yet.
We don't have any PDF documents related to ATC code L02 yet.
We don't have any Books related to ATC code L02 yet.
We don't have any archived web articles related to ATC code L02 yet.

L02AA Estrogens

L02AA01 Diethylstilbestrol L02AA02 Polyestradiol phosphate L02AA03 Ethinylestradiol L02AA04 Fosfestrol

L02AB Progestogens

L02AB01 Megestrol L02AB02 Medroxyprogesterone L02AB03 Gestonorone

L02AE Gonadotropin-releasing hormone analogues

L02AE01 Buserelin L02AE02 Leuprorelin L02AE03 Goserelin L02AE04 Triptorelin L02AE05 Histrelin L02AE51 Leuprorelin and bicalutamide

L02AX Other hormones

L02BA Anti-estrogens

L02BA01 Tamoxifen L02BA02 Toremifene L02BA03 Fulvestrant L02BA04 Elacestrant

L02BB Anti-androgens

L02BB01 Flutamide L02BB02 Nilutamide L02BB03 Bicalutamide L02BB04 Enzalutamide L02BB05 Apalutamide L02BB06 Darolutamide

L02BG Aromatase inhibitors

L02BG01 Aminogluthetimide L02BG02 Formestane L02BG03 Anastrozole L02BG04 Letrozole L02BG05 Vorozole L02BG06 Exemestane

L02BX Other hormone antagonists and related agents

L02BX01 Abarelix L02BX02 Degarelix L02BX03 Abiraterone L02BX04 Relugolix L02BX53 Abiraterone and corticosteroids

References

  1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/ATC/index.html ↩

  2. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022. https://www.who.int/tools/atc-ddd-toolkit/atc-classification ↩

  3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022. https://www.whocc.no/atc/structure_and_principles/ ↩

  4. "ATC/DDD Index 2022: code L02". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/?code=L02 ↩

  5. "ATCvet Index 2022: code QL02". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcvet/atcvet_index/?code=L02 ↩